Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI)

NCT ID: NCT03000920

Last Updated: 2019-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-02

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Each year in France, breast cancer affects about 48,000 women and is the first cause of cancer death in women with 11,900 deaths estimated.

Since 2004, there is a national organized breast cancer screening (OBCS) programme for asymptomatic women aged 50-74 and with a medium-risk. Every two years, the local cancer screening department sends a personalized invitation mail to eligible women to perform a mammogram and a breast clinical examination. One to two reminder mails are sent to women who have not done the screening after an initial invitation. Despite this programme, almost 47% of women in France do not participate to organized breast cancer screening.

The Short Message Service (SMS) is an innovative communication tool in the field of health, immediate, reliable delivery, low cost and ecological. The use of SMS could be an innovative, low-cost, personalized and ecological way to support the OBCS invitation strategy.

The overall objective of this study is to preserve or even better increase participation in organized breast cancer screening while decreasing the associated costs by including SMS in our screening invitation procedure.

Two SMS interventions will be tested which will correspond to different phases of the OBCS invitation procedure. This sequence of interventions leads us to perform three interlinked trials: a trial of superiority for the first phase (intervention 1: sending an SMS a few days before the initial mail invitation), then two non-inferiority trials for the second phase ( two trials=one for each context of phase 1 \_ intervention 2: sending an SMS in place of the first postal reminder).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each year in France, breast cancer affects about 48,000 women and is the first cause of cancer death in women with 11,900 deaths estimated.

Since 2004, there is a national organized breast cancer screening (OBCS) programme for asymptomatic women aged 50-74 and with a medium-risk. Every two years, the local cancer screening department sends a personalized invitation mail to eligible women to perform a mammogram and a breast clinical examination. One to two reminder mails are sent to women who have not done the screening after an initial invitation. Despite this programme, almost 47% of women in France do not participate to organized breast cancer screening.

The Short Message Service (SMS) is an innovative communication tool in the field of health, immediate, reliable delivery, low cost and ecological. The use of SMS could be an innovative, low-cost, personalized and ecological way to support the OBCS invitation strategy.

In databases, there is currently about 10 to 15% of the women with a mobile phone number registered in the target population.

This project will be carried out throughout the Region "Centre-Val de Loire" with six local cancer screening departments The overall objective of this study is to preserve or even better increase participation in organized breast cancer screening while decreasing the associated costs by including SMS in our screening invitation procedure.

Two SMS interventions will be tested which will correspond to different phases of the OBCS invitation procedure. This sequence of interventions leads us to perform three interlinked trials: a trial of superiority for the first phase (intervention 1: sending an SMS a few days before the initial mail invitation), then two non-inferiority trials for the second phase (intervention 2: sending an SMS in place of the first postal reminder).

Justification of methodological choices

1. st phase: Addition of the intervention "sending an SMS" (and the associated cost) to what is currently done (versus classical intervention). To be of interest, the tested intervention, the sending of an SMS few days before the initial mail invitation, should allow to significantly increase participation in OBCS (here superiority trial).
2. nd phase: This phase will involve women who have had or not the phase 1 intervention and who have not yet participated to the OBCS. Since the contexts in phase 1 are different, a trial for each one must be carry out. In this second phase, the conventional intervention (sending reminder mail 1) will be compare to a cheaper one (sending reminder 1 by SMS). The new strategy will prove interesting if it is not inferior in terms of participation to the OBCS. The analysis of this non-inferiority will be carried out for each context of phase 1 (invitation mail alone OR SMS then invitation mail).

The 4 groups of the study are the followings:

* Group 1 (usual procedure): at least an invitation mail and then one or two reminder by mail if necessary.
* Group 2 : Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary
* Group 3 : One SMS a few days before the Invitation by mail and then one or two reminder(s) by mail if necessary
* Group 4 : One SMS a few days before the Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1_Control

Classic screening invitation strategy with at least an invitation mail and then one or two reminder by mail if necessary.

Group Type NO_INTERVENTION

No interventions assigned to this group

2_SMS Reminder 1

Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary

Group Type EXPERIMENTAL

SMS Reminder 1

Intervention Type OTHER

If it is necessary for the women to have a reminder 1, the usual mail will be replaced by an SMS.

3_SMS before invitation

One SMS a few days before the Invitation by mail and then one or two reminder(s) by mail if necessary.

Group Type EXPERIMENTAL

SMS before invitation

Intervention Type OTHER

A couple of days before the invitation letter, an SMS will be sent to announce the arrival of the invitation letter to the mammogram

4_SMS before invitation + SMS Reminder 1

One SMS a few days before the Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary

Group Type EXPERIMENTAL

SMS before invitation

Intervention Type OTHER

A couple of days before the invitation letter, an SMS will be sent to announce the arrival of the invitation letter to the mammogram

SMS Reminder 1

Intervention Type OTHER

If it is necessary for the women to have a reminder 1, the usual mail will be replaced by an SMS.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS before invitation

A couple of days before the invitation letter, an SMS will be sent to announce the arrival of the invitation letter to the mammogram

Intervention Type OTHER

SMS Reminder 1

If it is necessary for the women to have a reminder 1, the usual mail will be replaced by an SMS.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* eligible to the organized breast cancer screening
* residing in the region of Centre-Val de Loire (France)
* Phone number registered in data bases of one of the 6 local cancer screening departments of the region of Centre-Val de Loire (France)

Exclusion Criteria

* none
Minimum Eligible Age

50 Years

Maximum Eligible Age

74 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ken HAGUENOER, Dr

Role: PRINCIPAL_INVESTIGATOR

Centre de Coordination des Dépistages des Cancers, CHRU de Tours

Somany SENGCHANH, Dr

Role: PRINCIPAL_INVESTIGATOR

Centre de Coordination des Dépistages des Cancers, CHRU de Tours

Julie Boyard

Role: PRINCIPAL_INVESTIGATOR

Centre de Coordination des Dépistages des Cancers, CHRU de Tours

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ADOC41

Blois, , France

Site Status

ADOC28

Chartres, , France

Site Status

CREDEP

Châteauroux, , France

Site Status

CCDC

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INCA15-KH/USIMaPI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Elevate! : An Elderly Breast Cancer Cohort Study
NCT03818087 ACTIVE_NOT_RECRUITING